老年NSAID相关严重胃肠并发症风险预测评分的建立与验证
研究基于韩国医保数据建立并外部验证老年NSAID使用者严重胃肠并发症风险预测评分。预测因子包括高剂量NSAID、非选择性NSAID、复杂性胃肠溃疡史等,外部验证AUC为0.79(95%CI 0.77-0.81)。
要点
- 外部验证AUC为0.79(95%CI 0.77-0.81),区分度良好。
- 预测因子含高剂量NSAID、非选择性NSAID及复杂性胃肠溃疡史等。
- 可用于识别老年NSAID使用者中严重胃肠并发症高危人群。
核心结论
- 该预测模型可通过识别高危老年患者,有助于降低严重胃肠并发症风险。
研究设计与样本
- 采用logistic LASSO回归进行变量选择与模型拟合。
主要发现
- 外部验证数据集AUC为0.79(95%CI 0.77-0.81)。
- 风险预测因子包括高剂量NSAID、非选择性NSAID、复杂性胃肠溃疡史、男性、合并使用胃保护剂、相关合并用药、严重肾病及肝硬化。
关键数值与推荐
- NSAID使用者定义为≥65岁且接受NSAID超过30天。
- 严重胃肠并发症定义为以胃肠出血或穿孔为主要诊断的住院或急诊就诊。
临床怎么用
- 对≥65岁、使用NSAID超过30天者可用该评分识别高危患者并加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Few studies have quantified the impact of risk factors on GI complications in elderly nonsteroidal anti-inflammatory drug (NSAID) users. This study aimed to develop and validate a risk prediction score for severe GI complications to identify high-risk elderly patients using NSAID. METHODS: We used the following two Korean claims datasets: customized data with an enrolment period 2016-2017 for model development, and the sample data in 2019 for external validation. We conducted a nested case-control study for model development and validation. NSAID users were identified as the elderly (≥65 years) who received NSAIDs for more than 30 days. Serious GI complications were defined as hospitalizations or emergency department visits, with a main diagnosis of GI bleeding or perforation. We applied the logistic least absolute shrinkage and selection operator (LASSO) regression model for variable selection and model fitting. RESULTS: We identified 8176 cases and 81 760 controls with a 1:10 matched follow-up period in the derivation cohort. In the external validation cohort, we identified 372 cases from 254 551 patients. The risk predictors were high-dose NSAIDs, nonselective NSAID, complicated GI ulcer history, male sex, concomitant gastroprotective agents, relevant co-medications, severe renal disease and cirrhosis. Area under the receiver operating characteristic curve was 0.79 (95% confidence interval, 0.77-0.81) in the external validation dataset. CONCLUSIONS: The prediction model may be a useful tool for reducing the risk of serious GI complications by identifying high-risk elderly patients.
引用
- Lee S, Heo KN, Lee MY, et al. Derivation and validation of a risk prediction score for nonsteroidal anti-inflammatory drug-related serious gastrointestinal complications in the elderly. Br J Clin Pharmacol. 2023. PMID: 36807272. doi:10.1111/bcp.15696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。